• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥厚型心肌病中左心室流出道梗阻作为心脏性猝死的危险因素

Left ventricular outflow tract obstruction as a risk factor for sudden cardiac death in hypertrophic cardiomyopathy.

作者信息

Efthimiadis Georgios K, Parcharidou Despina G, Giannakoulas Georgios, Pagourelias Efstathios D, Charalampidis Panagiotis, Savvopoulos Gregorios, Ziakas Antonios, Karvounis Haralambos, Styliadis Ioannis H, Parcharidis Georgios E

机构信息

First Cardiology Department, Cardiomyopathies Laboratory, Aristotle University of Thessaloniki Medical School, AHEPA Hospital, Thessaloniki, Greece.

出版信息

Am J Cardiol. 2009 Sep 1;104(5):695-9. doi: 10.1016/j.amjcard.2009.04.039. Epub 2009 Jun 24.

DOI:10.1016/j.amjcard.2009.04.039
PMID:19699347
Abstract

The effect of left ventricular outflow tract obstruction (LVOTO) at rest on the incidence of sudden death (SD) in patients with hypertrophic cardiomyopathy is rather conflicting. The aim of this study was the evaluation of LVOTO at rest as a new potential risk factor for SD in hypertrophic cardiomyopathy. A total of 166 patients (112 men, 51.8 +/- 15.6 years) were studied; 50 patients (30.1%) had peak instantaneous LVOTO gradients of > or = 30 mm Hg at rest. During the follow-up period (median 32.4 months, range 1 to 209), 13 patients either died suddenly, or had cardiac arrest, documented sustained ventricular tachycardia, or implantable cardioverter defibrillator discharge. The cumulative event-free survival rate was 92% in patients with LVOTO, and 92% in patients without obstruction (p = NS). LVOTO at rest was associated with a particularly low positive predictive value for SD (8%), although a high negative predictive value (92%) was recorded. Patients having syncope or presenting with a maximum wall thickness > or =3 cm in echocardiography were more sensitive to SD emergence because they had a 13.07 (95% confidence interval 4.00 to 46.95, p <0.0001) and a 10.07 (95% confidence interval 2.92 to 34.79, p = 0.003) greater relative risk, respectively. In conclusion, our cohort study results do not support LVOTO as an independent risk factor for SD in patients with hypertrophic cardiomyopathy.

摘要

肥厚型心肌病患者静息时左心室流出道梗阻(LVOTO)对猝死(SD)发生率的影响存在相当大的争议。本研究的目的是评估静息时的LVOTO作为肥厚型心肌病患者SD的一个新的潜在危险因素。共研究了166例患者(112例男性,年龄51.8±15.6岁);50例患者(30.1%)静息时左心室流出道峰值瞬时梯度≥30 mmHg。在随访期间(中位时间32.4个月,范围1至209个月),13例患者发生猝死、心脏骤停、记录到持续性室性心动过速或植入式心脏复律除颤器放电。LVOTO患者的累积无事件生存率为92%,无梗阻患者为92%(p=无显著性差异)。静息时的LVOTO对SD的阳性预测值特别低(8%),尽管记录到较高的阴性预测值(92%)。有晕厥或超声心动图显示最大壁厚≥3 cm的患者对SD的发生更敏感,因为他们的相对风险分别高13.07(95%置信区间4.00至46.95,p<0.0001)和10.07(95%置信区间2.92至34.79,p=0.003)。总之,我们的队列研究结果不支持LVOTO作为肥厚型心肌病患者SD的独立危险因素。

相似文献

1
Left ventricular outflow tract obstruction as a risk factor for sudden cardiac death in hypertrophic cardiomyopathy.肥厚型心肌病中左心室流出道梗阻作为心脏性猝死的危险因素
Am J Cardiol. 2009 Sep 1;104(5):695-9. doi: 10.1016/j.amjcard.2009.04.039. Epub 2009 Jun 24.
2
Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy.肥厚型心肌病患者的左心室流出道梗阻与猝死风险
Eur Heart J. 2006 Aug;27(16):1933-41. doi: 10.1093/eurheartj/ehl041. Epub 2006 Jun 5.
3
Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.肥厚型心肌病中的植入式心脏复律除颤器
Rev Port Cardiol. 2005 Mar;24(3):407-15.
4
Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy.外科室间隔心肌切除术可降低梗阻性肥厚型心肌病患者植入式心律转复除颤器恰当放电的风险。
Eur Heart J. 2007 Nov;28(21):2583-8. doi: 10.1093/eurheartj/ehm117. Epub 2007 May 4.
5
Prevalence of exercise-induced left ventricular outflow tract obstruction in symptomatic patients with non-obstructive hypertrophic cardiomyopathy.有症状的非梗阻性肥厚型心肌病患者运动诱发左心室流出道梗阻的患病率
Heart. 2008 Oct;94(10):1288-94. doi: 10.1136/hrt.2007.126003. Epub 2007 Nov 21.
6
Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy.肥厚型心肌病患者动态心电图心律失常的谱及预后意义
J Am Coll Cardiol. 2005 Mar 1;45(5):697-704. doi: 10.1016/j.jacc.2004.11.043.
7
Exercise-induced ventricular arrhythmias and risk of sudden cardiac death in patients with hypertrophic cardiomyopathy.运动诱发的室性心律失常与肥厚型心肌病患者心源性猝死的风险。
Eur Heart J. 2009 Nov;30(21):2599-605. doi: 10.1093/eurheartj/ehp327. Epub 2009 Aug 17.
8
ST-segment depression as a risk factor in hypertrophic cardiomyopathy.ST段压低作为肥厚型心肌病的一个危险因素。
Europace. 2009 May;11(5):643-9. doi: 10.1093/europace/eun393. Epub 2009 Jan 22.
9
Syncope and risk of sudden death in hypertrophic cardiomyopathy.肥厚型心肌病中的晕厥与猝死风险
Circulation. 2009 Apr 7;119(13):1703-10. doi: 10.1161/CIRCULATIONAHA.108.798314. Epub 2009 Mar 23.
10
Ventricular arrhythmia following alcohol septal ablation for obstructive hypertrophic cardiomyopathy.酒精室间隔消融治疗梗阻性肥厚型心肌病后的室性心律失常
Am J Cardiol. 2009 Jul 1;104(1):128-32. doi: 10.1016/j.amjcard.2009.02.056. Epub 2009 May 4.

引用本文的文献

1
Mexican guidelines 2024 for the diagnosis and treatment of hypertrophic cardiomyopathy.《2024年墨西哥肥厚型心肌病诊断与治疗指南》
Arch Cardiol Mex. 2024;94(Supl 4):1-75. doi: 10.24875/ACM.M25000098.
2
Prognosis of Patients with Hypertrophic Obstructive Cardiomyopathy: A Multicenter Cohort Study with Data-Driven Propensity Score Matching Analysis.肥厚型梗阻性心肌病患者的预后:一项基于数据驱动倾向评分匹配分析的多中心队列研究
Rev Cardiovasc Med. 2023 Sep 21;24(9):267. doi: 10.31083/j.rcm2409267. eCollection 2023 Sep.
3
Clinical profile and outcomes of pediatric hypertrophic cardiomyopathy in a South Indian tertiary care cardiac center: a three decade experience.
印度南部一家三级心脏护理中心小儿肥厚型心肌病的临床特征和结局:三十年经验。
BMC Pediatr. 2023 Sep 7;23(1):446. doi: 10.1186/s12887-023-04255-z.
4
Arrhythmic Risk Stratification among Patients with Hypertrophic Cardiomyopathy.肥厚型心肌病患者的心律失常风险分层
J Clin Med. 2023 May 10;12(10):3397. doi: 10.3390/jcm12103397.
5
Penetrance of Hypertrophic Cardiomyopathy in Sarcomere Protein Mutation Carriers.肌节蛋白基因突变携带者肥厚型心肌病的外显率。
J Am Coll Cardiol. 2020 Aug 4;76(5):550-559. doi: 10.1016/j.jacc.2020.06.011.
6
Mortality Among Referral Patients With Hypertrophic Cardiomyopathy vs the General European Population.转诊肥厚型心肌病患者与一般欧洲人群的死亡率比较。
JAMA Cardiol. 2020 Jan 1;5(1):73-80. doi: 10.1001/jamacardio.2019.4534.
7
Hypertrophic cardiomyopathy: genetics and clinical perspectives.肥厚型心肌病:遗传学与临床展望
Cardiovasc Diagn Ther. 2019 Oct;9(Suppl 2):S388-S415. doi: 10.21037/cdt.2019.02.01.
8
Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy: What has Changed in The Guidelines?肥厚型心肌病患者心脏性猝死的预防:指南有哪些变化?
Arq Bras Cardiol. 2018 Jun;110(6):524-531. doi: 10.5935/abc.20180099.
9
Risk stratification in hypertrophic cardiomyopathy.肥厚型心肌病的风险分层
Herz. 2020 Feb;45(1):50-64. doi: 10.1007/s00059-018-4700-8. Epub 2018 Apr 25.
10
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.《2017年心脏病和中风统计数据更新:美国心脏协会报告》
Circulation. 2017 Mar 7;135(10):e146-e603. doi: 10.1161/CIR.0000000000000485. Epub 2017 Jan 25.